[Quality of ulcer healing and rebamipide].
Fujiwara
Yasuhiro
Y
Department of Gastroenterology, Osaka City University, Graduate School of Medicine.
Higuchi
Kazuhide
K
Tominaga
Kazunari
K
Watanabe
Toshio
T
Arakawa
Tetsuo
T
D000409:Alanine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D000658:Amoxicillin / Q000627:therapeutic use; D000818:Animals; D000897:Anti-Ulcer Agents / Q000494:pharmacology / Q000627:therapeutic use*; D000975:Antioxidants; D016207:Cytokines / Q000037:antagonists & inhibitors; D004359:Drug Therapy, Combination; D016481:Helicobacter Infections; D016480:Helicobacter pylori; D006801:Humans; D009853:Omeprazole / Q000627:therapeutic use; D015363:Quinolones / Q000494:pharmacology / Q000627:therapeutic use*; D012008:Recurrence; D013276:Stomach Ulcer / Q000188:drug therapy* / Q000382:microbiology* / Q000503:physiopathology; D014945:Wound Healing
D000897:Anti-Ulcer Agents; D000975:Antioxidants; D016207:Cytokines; D015363:Quinolones; D000658:Amoxicillin; D009853:Omeprazole; C052785:rebamipide; D000409:Alanine